Patent Assignment
Reel/Frame 055693/0809
Assignment of Assignor's Interest
Recorded: 2021-03-23
Pages: 62
Assignor
SAMUMED, LLC
Executed: 2021-03-05
Assignee
BIOSPLICE THERAPEUTICS, INC.
9360 TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties
(50)
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Process for Preparing N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide
5-Substituted Indazole-3-Carboxamides and Preparation and Use Thereof
2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-B]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles
Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
2-(1H-Indazol-3-Yl)-1H-Imidazo[4,5-C]Pyridine and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof
3-(1H-Indol-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof
3-(1H-Indol-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B] Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Indol-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B] Pyridines and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-C]Pyridines and Their Anti-Inflammatory Uses Thereof
Treatment of Osteoarthritis
Methods of Using Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
Single-Dose, Ready-to-Use Injectable Formulations
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridine and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
3-(Benzoimidazol-2-Yl)-Indazole Inhibitors of the Wnt Signaling Pathway and Therapeutic Uses Thereof
Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-B]Pyridine and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
Process for Preparing N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 13, 2016
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; CAO, JIANGUO; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 040728/0294 →
Assignment of Assignor's Interest
Dec 29, 2016
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; CAO, JIANGUO; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 040804/0675 →
Assignment of Assignor's Interest
Feb 22, 2017
From: HOOD, JOHN; KC, SUNIL KUMAR; WALLACE, DAVID MARK
To: SAMUMED, LLC
Reel/Frame 041329/0562 →
Assignment of Assignor's Interest
May 16, 2017
From: KC, SUNIL KUMAR; MITTAPALLI, GOPI KUMAR; HOFILENA, BRIAN JOSEPH; MARAKOVITS, JOSEPH TIMOTHY
To: SAMUMED, LLC
Reel/Frame 042395/0105 →
Assignment of Assignor's Interest
May 16, 2017
From: KC, SUNIL KUMAR; MAK, CHI CHING; EASTMAN, BRIAN WALTER; CAO, JIANGUO
To: SAMUMED, LLC
Reel/Frame 042394/0128 →
Assignment of Assignor's Interest
May 23, 2017
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; CAO, JIANGUO; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 042472/0631 →
Assignment of Assignor's Interest
Jul 20, 2017
From: HOOD, JOHN; KUMAR KC, SUNIL; WALLACE, DAVID MARK; MITTAPALLI, GOPI KUMAR
To: SAMUMED, LLC
Reel/Frame 043052/0335 →
Assignment of Assignor's Interest
Aug 3, 2017
From: KUMAR KC, SUNIL; WALLACE, DAVID MARK; CAO, JIANGUO; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 043189/0079 →
Assignment of Assignor's Interest
Oct 10, 2017
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; CAO, JIANGUO; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 043822/0280 →
Assignment of Assignor's Interest
Feb 26, 2018
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 045038/0585 →
Assignment of Assignor's Interest
Mar 6, 2018
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; CAO, JIANGUO; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 045117/0266 →
Assignment of Assignor's Interest
Apr 24, 2018
From: KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 045621/0168 →
Assignment of Assignor's Interest
May 7, 2018
From: HOOD, JOHN; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 045732/0719 →
Assignment of Assignor's Interest
Jun 19, 2018
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; CAO, JIANGUO; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 046133/0308 →
Assignment of Assignor's Interest
Oct 10, 2018
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; CAO, JIANGUO; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 047121/0655 →
Assignment of Assignor's Interest
Apr 4, 2019
From: HOOD, JOHN; KC, SUNIL KUMAR; KIBAR, OSMAN; BARROGA, CHARLENE F.
To: SAMUMED, LLC
Reel/Frame 048799/0440 →
Assignment of Assignor's Interest
Jul 12, 2019
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; CAO, JIANGUO; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 049739/0653 →
Assignment of Assignor's Interest
Jul 19, 2019
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; CAO, JIANGUO; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 049800/0341 →
Assignment of Assignor's Interest
Sep 22, 2020
From: KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 053845/0696 →
Security Interest
Sep 14, 2022
From: BIOSPLICE THERAPEUTICS, INC.
To: VICKERS VENTURE FUND VI PTE. LTD.; VICKERS VENTURE FUND VI (PLAN) PTE. LTD.; VICKERS-SPLICE CO-INVESTMENT LLC; MED-PATHWAYS II LIMITED
Reel/Frame 061433/0786 →
Release of Security Interest
Mar 12, 2026
From: TMF GROUP NEW YORK, LLC, NOT INDIVIDUALLY BUT SOLELY AS COLLATERAL AGENT
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 075109/0434 →
Assignment of Assignor's Interest
Mar 27, 2026
From: BIOSPLICE THERAPEUTICS, INC.
To: TENARX, INC.
Reel/Frame 074209/0693 →